A Dipstick Test for Breast Cancer?
A few drops of urine may reveal whether a woman is at risk for Breast cancer, researchers led by Marsha Moses, PhD, of the Vascular Biology Program at Children’s Hospital Boston, have found. In tests, the urine of women with each of two types of Breast cancer had markedly elevated levels of certain biomarkers that indicate increased angiogenesis—known as MMP-9 and ADAM-12—as compared with controls.
The discoveries, licensed to the company Predictive Biosciences, may lead to simple “dipstick” tests for Breast cancer, catching the disease at the earliest stages or spotting a resurgence before it becomes a threat. Potentially, women whose urine revealed a risk for Breast cancer could get more frequent Mammograms and make lifestyle changes to minimize the odds.
Children’s Hospital Boston is home to the world’s largest research enterprise based at a pediatric medical center, where its discoveries have benefited both children and adults since 1869. More than 500 scientists, including eight members of the National Academy of Sciences, 11 members of the Institute of Medicine and 12 members of the Howard Hughes Medical Institute comprise Children’s research community.
Founded as a 20-bed hospital for children, Children’s Hospital Boston today is a 397-bed comprehensive center for pediatric and adolescent health care grounded in the values of excellence in patient care and sensitivity to the complex needs and diversity of children and families. Children’s also is the primary pediatric teaching affiliate of Harvard Medical School.
Source: Children’s Hospital Boston
Print Version
Tell-a-Friend
